-
市場
-
產品
-
資訊
-
Moo社區
-
課堂
-
查看更多
-
功能介紹
-
費用費用透明,無最低余額限制
投資選擇、功能介紹、費用相關信息由Moomoo Financial Inc.提供
- English
- 中文繁體
- 中文简体
- 深色
- 淺色
UK-Based Psychedelics Ancillary Business Wraps Up $3M Funding Round
UK-Based Psychedelics Ancillary Business Wraps Up $3M Funding Round
A tech company responsible for creating a clinical testing platform that uses AI and machine learning for the detection of earliest cognitive impairment signs, Cognetivity Neurosciences Ltd. (OTCQB:CGNSF), has completed its non-brokered private placement raising a total $3.323.279.
The oversubscribed offer, led by investment holding company SAYACORP B.S.C., resulted in the issuance of 15,525,786 convertible preferred shares at a price of $0.21 (CA$0.29) each, with all securities issued subject to a statutory hold period ending February 26, 2023.
Headquartered in Bahrain, SAYACORP was assisted by its subsidiary located at the Dubai International Financial Centre, SAYACORP CAPITAL LTD. As stated, the firm's shareholders are mainly sovereign wealth funds, leading institutions and family offices from the Gulf Cooperation Council (GCC) and Middle East and North Africa (MENA) region. Its portfolio includes investments in food manufacturing, healthcare, pharmaceuticals, energy, commercial property and aviation industries.
SAYACORP CAPITAL's CEO Mohamed Idriss says the company is at a very exciting and proactive investment moment, demonstrating "the group's vision of backing technology companies in massive growing markets at a stage when the most value can be realized" while also having a positive impact on people's lives.
"Cognetivity has an incredible technology platform that will have a great positive impact both commercially and socially, and as demonstrated by their early commercial success including in the Middle East, is truly globally scalable. This transaction is in line with the group's investment strategy, to work with undervalued firms which demonstrate potential and help them to become successful," Idriss added.
On behalf of Cognetivity, CEO Sina Habibi shared the company's eagerness towards the new financial partner: "SAYACORP is showing belief in our technology, strategy and team and is backing us to be a success in the huge global market for cognitive assessment, and their support is going to be enormously helpful in our development."
Habibi is confident that SAYACORP's backing will allow the company to make it to the next level by building on the early commercial success of its CognICATM clinical tool and growing the customer base and strategic partnerships in North America and furthermore.
Photo by Joshua Sortino on Unsplash
A tech company responsible for creating a clinical testing platform that uses AI and machine learning for the detection of earliest cognitive impairment signs, Cognetivity Neurosciences Ltd. (OTCQB:CGNSF), has completed its non-brokered private placement raising a total $3.323.279.
一家負責創造一種使用人工智能和機器學習的臨牀測試平臺對於最早認知損害體徵的檢測, 認知神經科學有限公司(OTCQB:CGNSF),已經完成了其非經紀私募共募集資金3.323.279美元。
The oversubscribed offer, led by investment holding company SAYACORP B.S.C., resulted in the issuance of 15,525,786 convertible preferred shares at a price of $0.21 (CA$0.29) each, with all securities issued subject to a statutory hold period ending February 26, 2023.
這個超額認購要約,由投資控股公司SAYACORP B.S.C.牽頭。,導致以每股0.21美元(0.29加元)的價格發行了15,525,786股可轉換優先股,所有發行的證券均受截至2023年2月26日的法定持有期的限制。
Headquartered in Bahrain, SAYACORP was assisted by its subsidiary located at the Dubai International Financial Centre, SAYACORP CAPITAL LTD. As stated, the firm's shareholders are mainly sovereign wealth funds, leading institutions and family offices from the Gulf Cooperation Council (GCC) and Middle East and North Africa (MENA) region. Its portfolio includes investments in food manufacturing, healthcare, pharmaceuticals, energy, commercial property and aviation industries.
總部設在巴林,SAYACORP得到了其位於迪拜國際金融中心的子公司SAYACORP Capital Ltd.的協助。如上所述,該公司的股東主要是來自海灣合作委員會(GCC)和中東北非(MENA)地區的主權財富基金、領先機構和家族理財室。其投資組合包括食品製造、醫療保健、製藥、能源、商業地產和航空行業的投資。
SAYACORP CAPITAL's CEO Mohamed Idriss says the company is at a very exciting and proactive investment moment, demonstrating "the group's vision of backing technology companies in massive growing markets at a stage when the most value can be realized" while also having a positive impact on people's lives.
SAYACORP Capital的首席執行官穆罕默德·伊德里斯表示,該公司正處於一個非常令人興奮和積極主動的投資時刻,展示了“集團的願景,即在能夠實現最大價值的階段,在巨大的成長型市場支持科技公司”同時也對人們的生活產生了積極的影響。
"Cognetivity has an incredible technology platform that will have a great positive impact both commercially and socially, and as demonstrated by their early commercial success including in the Middle East, is truly globally scalable. This transaction is in line with the group's investment strategy, to work with undervalued firms which demonstrate potential and help them to become successful," Idriss added.
伊德里斯補充道:“Cognetivity擁有一個令人難以置信的技術平臺,這將在商業和社會上產生巨大的積極影響,正如他們在中東等地的早期商業成功所證明的那樣,這筆交易是真正的全球可擴展的。這筆交易符合集團的投資戰略,與那些顯示出潛力並幫助它們取得成功的被低估的公司合作。”
On behalf of Cognetivity, CEO Sina Habibi shared the company's eagerness towards the new financial partner: "SAYACORP is showing belief in our technology, strategy and team and is backing us to be a success in the huge global market for cognitive assessment, and their support is going to be enormously helpful in our development."
我代表認知性,首席執行官新浪哈比比SAYACORP分享了公司對新的財務合作伙伴的熱忱:“SAYACORP對我們的技術、戰略和團隊表現出了信心,並支持我們在巨大的全球認知評估市場上取得成功,他們的支持將對我們的發展有很大幫助。”
Habibi is confident that SAYACORP's backing will allow the company to make it to the next level by building on the early commercial success of its CognICATM clinical tool and growing the customer base and strategic partnerships in North America and furthermore.
哈比比相信,SAYACORP的支持將使該公司在其CognICATM臨牀工具的早期商業成功的基礎上再接再厲,並在北美和其他地區擴大客户基礎和戰略夥伴關係,從而使公司更上一層樓。
Photo by Joshua Sortino on Unsplash
Unspash上的約書亞·索蒂諾攝
moomoo是Moomoo Technologies Inc.公司提供的金融資訊和交易應用程式。
在美國,moomoo上的投資產品和服務由Moomoo Financial Inc.提供,一家受美國證券交易委員會(SEC)監管的持牌主體。 Moomoo Financial Inc.是金融業監管局(FINRA)和證券投資者保護公司(SIPC)的成員。
在新加坡,moomoo上的投資產品和服務是通過Moomoo Financial Singapore Pte. Ltd.提供,該公司受新加坡金融管理局(MAS)監管(牌照號碼︰CMS101000) ,持有資本市場服務牌照 (CMS) ,持有財務顧問豁免(Exempt Financial Adviser)資質。本內容未經新加坡金融管理局的審查。
在澳大利亞,moomoo上的金融產品和服務是通過Futu Securities (Australia) Ltd提供,該公司是受澳大利亞證券和投資委員會(ASIC)監管的澳大利亞金融服務許可機構(AFSL No. 224663)。請閱讀並理解我們的《金融服務指南》、《條款與條件》、《隱私政策》和其他披露文件,這些文件可在我們的網站 https://www.moomoo.com/au中獲取。
在加拿大,透過moomoo應用程式提供的僅限訂單執行的券商服務由Moomoo Financial Canada Inc.提供,並受加拿大投資監管機構(CIRO)監管。
在馬來西亞,moomoo上的投資產品和服務是透過Moomoo Securities Malaysia Sdn. Bhd. 提供,該公司受馬來西亞證券監督委員會(SC)監管(牌照號碼︰eCMSL/A0397/2024) ,持有資本市場服務牌照 (CMSL) 。本內容未經馬來西亞證券監督委員會的審查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd.,Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc和Moomoo Securities Malaysia Sdn. Bhd., 是關聯公司。
風險及免責聲明
moomoo是Moomoo Technologies Inc.公司提供的金融資訊和交易應用程式。
在美國,moomoo上的投資產品和服務由Moomoo Financial Inc.提供,一家受美國證券交易委員會(SEC)監管的持牌主體。 Moomoo Financial Inc.是金融業監管局(FINRA)和證券投資者保護公司(SIPC)的成員。
在新加坡,moomoo上的投資產品和服務是通過Moomoo Financial Singapore Pte. Ltd.提供,該公司受新加坡金融管理局(MAS)監管(牌照號碼︰CMS101000) ,持有資本市場服務牌照 (CMS) ,持有財務顧問豁免(Exempt Financial Adviser)資質。本內容未經新加坡金融管理局的審查。
在澳大利亞,moomoo上的金融產品和服務是通過Futu Securities (Australia) Ltd提供,該公司是受澳大利亞證券和投資委員會(ASIC)監管的澳大利亞金融服務許可機構(AFSL No. 224663)。請閱讀並理解我們的《金融服務指南》、《條款與條件》、《隱私政策》和其他披露文件,這些文件可在我們的網站 https://www.moomoo.com/au中獲取。
在加拿大,透過moomoo應用程式提供的僅限訂單執行的券商服務由Moomoo Financial Canada Inc.提供,並受加拿大投資監管機構(CIRO)監管。
在馬來西亞,moomoo上的投資產品和服務是透過Moomoo Securities Malaysia Sdn. Bhd. 提供,該公司受馬來西亞證券監督委員會(SC)監管(牌照號碼︰eCMSL/A0397/2024) ,持有資本市場服務牌照 (CMSL) 。本內容未經馬來西亞證券監督委員會的審查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd.,Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc和Moomoo Securities Malaysia Sdn. Bhd., 是關聯公司。
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用瀏覽器的分享功能,分享給你的好友吧